Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

EGX:RMDA Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	128.59	64.69	52.36	66.96	14	13.23
Short-Term Investments	-	189.7	260.9	361.86	468.01	469.35
Cash & Short-Term Investments	128.59	254.39	313.25	428.82	482.01	482.58
Cash Growth	-56.77%	-18.79%	-26.95%	-11.04%	-0.12%	-6.99%
Accounts Receivable	791.22	791.26	353.74	276.6	265.96	238.41
Other Receivables	140.72	103.43	72.16	22.6	25.2	33.11
Receivables	1,687	1,582	1,344	923.28	684.61	666.63
Inventory	1,227	751.34	303.26	348.41	259.4	305.48
Prepaid Expenses	21.47	4.29	2.21	2.83	0.99	0.91
Other Current Assets	215.88	544.65	60.33	55.14	48.64	40.98
Total Current Assets	3,280	3,137	2,023	1,758	1,476	1,497
Property, Plant & Equipment	637.9	621.52	606.05	556.98	554.99	538.16
Other Intangible Assets	1,004	552.79	589.27	457.57	389.66	214.57
Total Assets	4,923	4,311	3,218	2,773	2,420	2,249
Accounts Payable	278.03	264.36	102.41	120.25	61.53	46.93
Accrued Expenses	284.3	115.09	76.44	62.92	37.31	21.18
Short-Term Debt	2,100	1,555	1,098	910.18	842.6	823.75
Current Portion of Long-Term Debt	-	-	-	-	21.95	58.85
Current Portion of Leases	3.43	4.48	4.81	3.66	3.13	2.6
Current Income Taxes Payable	60.73	98.78	60.59	53.71	33.49	18.31
Other Current Liabilities	55.3	117.77	30.67	31.23	22.05	18.71
Total Current Liabilities	2,782	2,155	1,373	1,182	1,022	990.33
Long-Term Debt	-	-	-	-	-	29.55
Long-Term Leases	5.38	7.19	11.7	16.34	12.26	14.81
Long-Term Deferred Tax Liabilities	66.21	77.28	58.23	51.56	40.5	31.06
Total Liabilities	2,853	2,240	1,443	1,250	1,075	1,066
Common Stock	377.75	378.23	375	250	250	192.15
Additional Paid-In Capital	316.68	327.51	377.7	397.52	486.97	486.97
Retained Earnings	1,333	1,351	1,022	921.68	610.87	505.79
Treasury Stock	-	-26.23	-26.23	-65.93	-	-
Comprehensive Income & Other	0.28	13.31	14.21	15.31	0.28	0.28
Total Common Equity	2,027	2,044	1,763	1,519	1,348	1,185
Minority Interest	41.96	27.38	12.94	4.59	-2.62	-1.62
Shareholders' Equity	2,069	2,072	1,775	1,523	1,345	1,184
Total Liabilities & Equity	4,923	4,311	3,218	2,773	2,420	2,249
Total Debt	2,109	1,566	1,114	930.18	879.94	929.56
Net Cash (Debt)	-1,980	-1,312	-801.18	-501.37	-397.93	-446.98
Net Cash Per Share	-1.31	-0.87	-0.53	-0.34	-0.26	-0.29
Filing Date Shares Outstanding	1,511	1,503	1,491	1,491	1,523	1,523
Total Common Shares Outstanding	1,511	1,503	1,491	1,478	1,523	1,523
Working Capital	498.52	981.82	650.11	576.53	453.59	506.26
Book Value Per Share	1.34	1.36	1.18	1.03	0.89	0.78
Tangible Book Value	1,023	1,491	1,173	1,061	958.45	970.62
Tangible Book Value Per Share	0.68	0.99	0.79	0.72	0.63	0.64
Land	18.64	18.64	18.64	18.64	18.64	18.64
Buildings	296.7	294.77	288.43	279.17	273.34	257.23
Machinery	674.89	646.31	585.04	533.6	491.55	462.1
Construction In Progress	35.76	33.46	38.09	12.86	27.04	26.59

Source: S&P Global Market Intelligence. Standard template. Financial Sources.